Judge Andrews Issues Claim Construction Ruling on Disputed Terms of Patents Covering Drug Used to Treat Pediatric ADHD
By Memorandum Opinion entered by The Honorable Richard G. Andrews in Shire LLC, et al. v. Teva Pharmaceuticals USA Inc., et al., Civil Action No. 10-329-RGA (D.Del., March 22, 2012), the Court issued its claim construction ruling on the disputed terms of three patents, U.S. Patent Numbers 5,854,290, 6,287,599 and 6,811,794, covering the drug Intuniv®, which is used to treat pediatric ADHD.
A complete copy of the Memorandum Opinion is attached.